2025-2026 Regular Session • US Congress Legislature
SB822: Scientific EXPERT Act of 2025 Scientific External Process for Educated Review of Therapeutics Act of 2025
Legislative Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.
Bill History
3/3/2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
Status Information
Current Status
Introduced(3/3/2025)
Chamber
Senate
Committee
Health, Education, Labor, And Pensions(Senate)
